US COVID-19 Fraud: Home-Use Fingerstick Collection Kits Promised Results Within 72 Hours
FDA warns Florida firm Modern Allergy Management and a testing lab abut an unapproved and mislabeled home-use fingerstick sample collection for COVID-19 test. The firm promised results within three days.
You may also be interested in...
A top FDA official said the agency has more than doubled its virology review staff to handle the cascade of EUA applications. He said the agency is prioritizing certain COVID-19 diagnostics during a recent webinar.
FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.
OTC access to any test to diagnose COVID-19 without supervision by a health care professional isn't on the near-term horizon for potential launches in the US. In addition to diagnostic kits, digital apps available to directly to consumers for COVID-19 testing on their own would face a steep climb to approval.